Laporan Laba Rugi 8432 - TTM - TSH Biopharm Corporation Limited

Laporan Laba Rugi (TTM)

Laporan Laba Rugi TSH Biopharm Corporation Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	442	448	418	432	431	413	432	437	450	741	765	826	983	811	867	932	1,051	1,116	1,202	1,236
Change (%)		1.27	-6.75	3.48	-0.32	-4.01	4.52	1.00	3.05	64.75	3.29	7.92	19.04	-17.54	6.86	7.54	12.78	6.16	7.76	2.80
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	164	163	157	166	169	166	175	177	181	351	366	402	501	411	423	455	512	533	594	603
Change (%)		-1.05	-3.70	6.15	1.58	-1.66	5.47	1.25	2.29	93.53	4.27	9.68	24.73	-17.95	2.96	7.44	12.57	4.13	11.37	1.58
% of Revenue	37.17	36.32	37.51	38.48	39.21	40.18	40.54	40.64	40.34	47.39	47.84	48.62	50.94	50.69	48.83	48.79	48.70	47.77	49.37	48.78

Gross Operating Profit	278	285	261	266	262	247	257	259	268	390	399	424	482	400	443	477	539	583	609	633
Change (%)		2.64	-8.49	1.88	-1.52	-5.53	3.89	0.83	3.56	45.29	2.41	6.32	13.65	-17.11	10.87	7.63	12.99	8.08	4.47	3.99
% of Revenue	62.83	63.68	62.49	61.52	60.79	59.82	59.46	59.36	59.66	52.61	52.16	51.38	49.06	49.31	51.17	51.21	51.30	52.23	50.63	51.22

SG&A	189	182	177	175	172	168	171	174	180	293	323	350	387	311	310	334	356	385	414	415
Change (%)		-3.67	-2.72	-1.42	-1.65	-2.12	1.39	2.06	3.55	62.40	10.23	8.55	10.42	-19.48	-0.47	7.73	6.64	8.09	7.65	0.08
% of Revenue	42.77	40.68	42.45	40.44	39.90	40.69	39.47	39.88	40.08	39.50	42.16	42.40	39.33	38.41	35.77	35.84	33.89	34.50	34.46	33.55

R&D	32	29	29	28	32	24	21	20	14	31	33	34	36	25	25	25	25	28	26	25
Change (%)		-11.54	0.32	-3.06	15.87	-27.25	-11.66	-3.65	-28.28	116.58	5.32	4.13	5.22	-30.85	2.18	-1.38	0.12	11.80	-7.41	-3.30
% of Revenue	7.33	6.40	6.89	6.45	7.50	5.69	4.81	4.59	3.19	4.20	4.28	4.13	3.65	3.06	2.93	2.68	2.38	2.51	2.16	2.03

OpEx	386	374	363	369	373	358	367	371	376	675	722	786	924	747	759	814	893	946	1,034	1,043
Change (%)		-3.22	-2.91	1.72	1.13	-4.09	2.43	1.35	1.24	79.49	6.91	8.92	17.51	-19.09	1.50	7.26	9.75	5.92	9.30	0.86
% of Revenue	87.27	83.41	86.85	85.37	86.62	86.55	84.81	85.11	83.61	91.09	94.28	95.15	93.92	92.15	87.53	87.31	84.96	84.78	85.99	84.36

Operating Income	56	74	55	63	58	56	66	65	74	66	44	40	60	64	108	118	158	170	169	193
Change (%)		32.02	-26.07	15.11	-8.83	-3.53	18.01	-0.94	13.40	-10.45	-33.63	-8.50	49.02	6.49	69.80	9.45	33.63	7.49	-0.80	14.74
% of Revenue	12.73	16.59	13.15	14.63	13.38	13.45	15.19	14.89	16.39	8.91	5.72	4.85	6.08	7.85	12.47	12.69	15.04	15.22	14.01	15.64

Interest Expense	-0	-0	-0	-0	-0	-0	-0	-0	-0	-1	-1	-1	-1	-1	-0	-0	-0	-0	-1	-1
Change (%)		-32.50	51.85	29.27	26.42	19.40	-16.25	-17.91	-23.64	1,564.29	32.76	22.52	9.67	-44.83	-31.25	-20.72	13.07	7.55	37.28	13.58
% of Revenue	-0.01	-0.01	-0.01	-0.01	-0.02	-0.02	-0.02	-0.01	-0.01	-0.09	-0.12	-0.14	-0.13	-0.08	-0.05	-0.04	-0.04	-0.04	-0.05	-0.06

Net Income	53	62	48	53	47	47	57	60	68	62	53	55	54	62	92	88	120	113	103	115
Change (%)		16.92	-22.74	10.37	-10.70	0.47	20.68	5.69	13.87	-9.53	-14.13	3.77	-2.51	15.30	48.80	-4.62	36.03	-5.50	-9.30	11.88
% of Revenue	11.91	13.75	11.39	12.15	10.89	11.39	13.15	13.76	15.21	8.35	6.94	6.68	5.47	7.64	10.64	9.44	11.39	10.14	8.53	9.28

Source: Capital IQ

TSH Biopharm Corporation Limited - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)